Publications by authors named "Ryuichi Kumata"

The pandemic HIV-1, HIV-1 group M, emerged from a single spillover event of its ancestral lentivirus from a chimpanzee. During human-to-human spread worldwide, HIV-1 diversified into multiple subtypes. Here, our interdisciplinary investigation mainly sheds light on the evolutionary scenario of the viral budding system of HIV-1 subtype C (HIV-1C), a most successfully spread subtype.

View Article and Find Full Text PDF

The repeated emergence of SARS-CoV-2 escape mutants from host immunity has obstructed the containment of the current pandemic and poses a serious threat to humanity. Prolonged infection in immunocompromised patients has received increasing attention as a driver of immune escape, and accumulating evidence suggests that viral genomic diversity and emergence of immune-escape mutants are promoted in immunocompromised patients. However, because immunocompromised patients comprise a small proportion of the host population, whether they have a significant impact on antigenic evolution at the population level is unknown.

View Article and Find Full Text PDF

In HIV-1-infected individuals, transmitted/founder (TF) virus contributes to establish new infection and expands during the acute phase of infection, while chronic control (CC) virus emerges during the chronic phase of infection. TF viruses are more resistant to interferon-alpha (IFN-α)-mediated antiviral effects than CC virus, however, its virological relevance in infected individuals remains unclear. Here we perform an experimental-mathematical investigation and reveal that IFN-α strongly inhibits cell-to-cell infection by CC virus but only weakly affects that by TF virus.

View Article and Find Full Text PDF
Article Synopsis
  • - The APOBEC3 deaminases are key players in preventing virus replication and stopping viruses from jumping between species, especially in the case of simian immunodeficiency virus (SIV) to humans.
  • - For SIV to successfully transmit from chimpanzees to gorillas, the viral infectivity factor (Vif) must evolve to neutralize the gorilla's APOBEC3 enzymes, which serve as a barrier.
  • - The study shows that a specific change in the SIV Vif protein can help overcome this barrier, and it reveals that the Vif mechanism for degrading gorilla APOBEC3F differs from that in humans, highlighting adaptations that may have aided SIV's transmission to humans.
View Article and Find Full Text PDF

Background: Human-resident microbes can influence both health and disease. Investigating the microbiome using next-generation sequencing technology has revealed examples of mutualism and conflict between microbes and humans. Comparing to bacteria, the viral component of the microbiome (i.

View Article and Find Full Text PDF

Approximately, 1% of human population possesses a copy of human herpesvirus 6A and 6B (HHV-6A/B) in the genome. This viral element is referred to as inherited chromosomally integrated HHV-6A/B (iciHHV-6A/B) and is encoded in all of their cells. A recent study revealed that iciHHV-6A/B potentially increases the immune responses against HHV-6.

View Article and Find Full Text PDF

Background: The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; A3) gene family appears only in mammalian genomes. Some A3 proteins can be incorporated into progeny virions and inhibit lentiviral replication. In turn, the lentiviral viral infectivity factor (Vif) counteracts the A3-mediated antiviral effect by degrading A3 proteins.

View Article and Find Full Text PDF

Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) is a mammalian protein that restricts lentiviral replication. Various polymorphisms of mammalian genes have been observed in humans, Old World monkeys and domestic cats; however, the genetic diversity of genes in other mammals remains unaddressed. Here we identify a novel haplotype of the feline gene, an gene that restricts feline immunodeficiency virus (FIV) replication, in a Eurasian lynx ().

View Article and Find Full Text PDF